Non-resection approaches for colorectal liver metastases

Surgical Clinics of North America

Volumn 84, Issue 2, 2004, Pages 587-606

  Khatri, Vijay P ^a   McGahan, John ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IRINOTECAN; OXALIPLATIN;

CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CRYOSURGERY; CRYOTHERAPY; HEAT TREATMENT; HUMAN; IMAGING SYSTEM; LIVER BLOOD FLOW; LIVER METASTASIS; LIVER NECROSIS; LIVER SCINTISCANNING; LOW LEVEL LASER THERAPY; MICROWAVE THERAPY; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RADIOFREQUENCY; REVIEW; SURGEON; SURGICAL TECHNIQUE; TUMOR LOCALIZATION; TUMOR VOLUME; ULTRASOUND; UNITED STATES;

ADMINISTRATION, CUTANEOUS; CATHETER ABLATION; COLORECTAL NEOPLASMS; CRYOSURGERY; ETHANOL; HEPATECTOMY; HUMANS; LAPAROSCOPY; LASER SURGERY; LIVER NEOPLASMS; MICROWAVES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 1642293896     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2003.12.007     Document Type: Review

References (62)

1. Bengmark S., Hafstrom L., Jeppsson B., Jonsson P.E., Ryden S., Sundqvist K. Metastatic disease in the liver from colorectal cancer: an appraisal of liver surgery. World J Surg. 6:(1):1982;61-65.
2. Adson M.A., van Heerden J.A., Adson M.H., Wagner J.S., Ilstrup D.M. Resection of hepatic metastases from colorectal cancer. Arch Surg. 119:(6):1984;647-651.
3. Scheele J., Stangl R., Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg. 77:(11):1990;1241-1246.
4. Stangl R., Altendorf-Hofmann A., Charnley R.M., Scheele J. Factors influencing the natural history of colorectal liver metastases. Lancet. 343:(8910):1994;1405-1410.
5. Gibbs J.F., Weber T.K., Rodriguez-Bigas M.A., Driscoll D.L., Petrelli N.J. Intraoperative determinants of unresectability for patients with colorectal hepatic metastases. Cancer. 82:(7):1998;1244-1249.
6. Steele G.J., Ravikumar T.S. Resection of hepatic metastases from colorectal metastases: biologic perspectives. Ann Surg. 210:1989;127-138.
7. Scheele J., Stang R., Altendorf-Hofmann A., Paul M. Resection of colorectal liver metastases. World J Surg. 19:(1):1995;59-71.
8. Douillard J.Y., Cunningham D., Roth A.D., Navarro M., James R.D., Karasek P., et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet. 355:(9209):2000;1041-1047.
9. Saltz L.B., Douillard J.Y., Pirotta N., Alakl M., Gruia G., Awad L., et al. Irinotecan plus fluorouracil/leucovorin for metastatic colorectal cancer: a new survival standard. Oncologist. 6:(1):2001;81-91.
10. de Gramont A., Figer A., Seymour M., Homerin M., Hmissi A., Cassidy J., et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol. 18:(16):2000;2938-2947.
11. Adam R., Avisar E., Ariche A., Giachetti S., Azoulay D., Castaing D., et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol. 8:(4):2001;347-353.
12. Adam R., Laurent A., Azoulay D., Castaing D., Bismuth H. Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg. 232:(6):2000;777-785.
13. Hemming A.W., Reed A.I., Howard R.J., Fujita S., Hochwald S.N., Caridi J.G., et al. Preoperative portal vein embolization for extended hepatectomy. Ann Surg. 237:(5):2003;686-693.
14. Barbaro B., Di Stasi C., Nuzzo G., Vellone M., Giuliante F., Marano P. Preoperative right portal vein embolization in patients with metastatic liver disease. Metastatic liver volumes after RPVE. Acta Radiol. 44:(1):2003;98-102.
15. Jaeck D., Bachellier P., Nakano H., Oussoultzoglou E., Weber J.C., Wolf P., et al. One or two-stage hepatectomy combined with portal vein embolization for initially nonresectable colorectal liver metastases. Am J Surg. 185:(3):2003;221-229.
16. Liu L.X., Zhang W.H., Jiang H.C. Current treatment for liver metastases from colorectal cancer. World J Gastroenterol. 9:(2):2003;193-200.
17. Imamura H., Kawasaki S. Treatment strategy for multiple hepatic metastases of colorectal carcinoma. J Hepatobiliary Pancreat Surg. 6:(1):1999;23-29.
18. Minagawa M., Makuuchi M., Torzilli G., Takayama T., Kawasaki S., Kosuge T., et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg. 231:(4):2000;487-499.
19. Livraghi T., Bolondi L., Buscarini L., Cottone M., Mazziotti A., Morabito A., et al. No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. Italian cooperative HCC study group. J Hepatol. 22:(5):1995;522-526.
20. Bartolozzi C., Lencioni R. Ethanol injection for the treatment of hepatic tumours. Eur Radiol. 6:(5):1996;682-696.
21. Giovannini M., Seitz J.F. Ultrasound-guided percutaneous alcohol injection of small liver metastases. Results in 40 patients. Cancer. 73:(2):1994;294-297.
22. Giorgio A., Tarantino L., Mariniello N., De Stefano G., Perrotta A., Aloisio V., et al. Ultrasonography-guided percutaneous ethanol injection in large an/or multiple liver metastasis. Radiol Med (Torino). 96:(3):1998;238-242.
23. Livraghi T., Vettori C., Lazzaroni S. Liver metastases: results of percutaneous ethanol injection in 14 patients. Radiology. 179:(3):1991;709-712.
24. Mazziotti A., Grazi G.L., Gardini A., Cescon M., Pierangeli F., Ercolani G., et al. An appraisal of percutaneous treatment of liver metastases. Liver Transpl Surg. 4:(4):1998;271-275.
25. Seifert J.K., Morris D.L. Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer. Ann Surg. 228:(2):1998;201-208.
26. Adam R., Akpinar E., Johann M., Kunstlinger F., Majno P., Bismuth H. Place of cryosurgery in the treatment of malignant liver tumors. Ann Surg. 225:(1):1997;39-48. [discussion 48-50].
27. Onik G., Rubinsky B., Zemel R., Weaver L., Diamond D., Cobb C., et al. Ultrasound-guided hepatic cryosurgery in the treatment of metastatic colon carcinoma. Preliminary results. Cancer. 67:(4):1991;901-907.
28. Ruers T.J., Joosten J., Jager G.J., Wobbes T. Long-term results of treating hepatic colorectal metastases with cryosurgery. Br J Surg. 88:(6):2001;844-849.
29. Preketes A.P., Caplehorn J.R., King J., Clingan P.R., Ross W.B., Morris D.L. Effect of hepatic artery chemotherapy on survival of patients with hepatic metastases from colorectal carcinoma treated with cryotherapy. World J Surg. 19:(5):1995;768-771.
30. Bilchik A.J., Wood T.F., Allegra D., Tsioulias G.J., Chung M., Rose D.M., et al. Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm. Arch Surg. 135:(6):2000;657-662. [discussion 662-4].
31. d'Arsonval M.A. Action physiologique des courantsalternatifs. CR Soc Biol. 43:1891;283-286.
32. LeVeen H.H., Pontiggia P. Radiofrequency thermotherapy (RFTT) in the treatment of cancer. Prog Clin Biol Res. 107:1982;731-738.
33. McGahan J.P., Browning P.D., Brock J.M., Tesluk H. Hepatic ablation using radiofrequency electrocautery. Invest Radiol. 25:(3):1990;267-270.
34. Rossi S., Fornari F., Pathies C., Buscarini L. Thermal lesions induced by 480 KHz localized current field in guinea pig and pig liver. Tumori. 76:(1):1990;54-57.
35. Machi J., Uchida S., Sumida K., Limm W.M., Hundahl S.A., Oishi A.J., et al. Ultrasound-guided radiofrequency thermal ablation of liver tumors: percutaneous, laparoscopic, and open surgical approaches. J Gastrointest Surg. 5:(5):2001;477-489.
36. Machi J., Oishi A.J., Mossing A.J., Furumoto N.L., Oishi R.H. Hand-assisted laparoscopic ultrasound-guided radiofrequency thermal ablation of liver tumors: a technical report. Surg Laparosc Endosc Percutan Tech. 12:(3):2002;160-164.
37. Bleicher R.J., Allegra D.P., Nora D.T., Wood T.F., Foshag L.J., Bilchik A.J. Radiofrequency ablation in 447 complex unresectable liver tumors: lessons learned. Ann Surg Oncol. 10:(1):2003;52-58.
38. Solbiati L., Ierace T., Goldberg S.N., Sironi S., Livraghi T., Fiocca R., et al. Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients. Radiology. 202:(1):1997;195-203.
39. Goldberg S.N., Gazelle G.S., Compton C.C., Mueller P.R., Tanabe K.K. Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer. 88:(11):2000;2452-2463.
40. Langenhoff B.S., Oyen W.J., Jager G.J., Strijk S.P., Wobbes T., Corstens F.H., et al. Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study. J Clin Oncol. 20:(22):2002;4453-4458.
41. Solbiati L., Livraghi T., Goldberg S.N., Ierace T., Meloni F., Dellanoce M., et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology. 221:(1):2001;159-166.
42. de Baere T., Elias D., Dromain C., Din M.G., Kuoch V., Ducreux M., et al. Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR Am J Roentgenol. 175:(6):2000;1619-1625.
43. Wong S.L., Edwards M.J., Chao C., Simpson D., McMasters K.M. Radiofrequency ablation for unresectable hepatic tumors. Am J Surg. 182:(6):2001;552-557.
44. Curley S.A., Izzo F., Delrio P., Ellis L.M., Granchi J., Vallone P., et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg. 230:(1):1999;1-8.
45. Livraghi T., Solbiati L., Meloni M.F., Gazelle G.S., Halpern E.F., Goldberg S.N. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology. 226:(2):2003;441-451.
46. Pearson A.S., Izzo F., Fleming R.Y., Ellis L.M., Delrio P., Roh M.S., et al. Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg. 178:(6):1999;592-599.
47. Goldberg S.N., Solbiati L., Hahn P.F., Cosman E., Conrad J.E., Fogle R., et al. Large-volume tissue ablation with radio frequency by using a clustered, internally cooled electrode technique: laboratory and clinical experience in liver metastases. Radiology. 209:(2):1998;371-379.
48. Miao Y., Ni Y., Yu J., Marchal G. A comparative study on validation of a novel cooled-wet electrode for radiofrequency liver ablation. Invest Radiol. 35:(7):2000;438-444.
49. Goldberg S.N., Stein M.C., Gazelle G.S., Sheiman R.G., Kruskal J.B., Clouse M.E. Percutaneous radiofrequency tissue ablation: optimization of pulsed- radiofrequency technique to increase coagulation necrosis. J Vasc Interv Radiol. 10:(7):1999;907-916.
50. Scott D.J., Fleming J.B., Watumull L.M., Lindberg G., Tesfay S.T., Jones D.B. The effect of hepatic inflow occlusion on laparoscopic radiofrequency ablation using simulated tumors. Surg Endosc. 16:(9):2002;1286-1291.
51. Chinn S.B., Lee F.T. Jr., Kennedy G.D., Chinn C., Johnson C.D., Winter T.C. III, et al. Effect of vascular occlusion on radiofrequency ablation of the liver: results in a porcine model. AJR Am J Roentgenol. 176:(3):2001;789-795.
52. Goldberg S.N., Kamel I.R., Kruskal J.B., Reynolds K., Monsky W.L., Stuart K.E., et al. Radiofrequency ablation of hepatic tumors: increased tumor destruction with adjuvant liposomal doxorubicin therapy. AJR Am J Roentgenol. 179:(1):2002;93-101.
53. Shetty S.K., Rosen M.P., Raptopoulos V., Goldberg S.N. Cost-effectiveness of percutaneous radiofrequency ablation for malignant hepatic neoplasms. J Vasc Interv Radiol. 12:(7):2001;823-833.
54. Vogl T.J., Muller P.K., Mack M.G., Straub R., Engelmann K., Neuhaus P. Liver metastases: interventional therapeutic techniques and results, state of the art. Eur Radiol. 9:(4):1999;675-684.
55. Gillams A.R., Lees W.R. Survival after percutaneous, image-guided, thermal ablation of hepatic metastases from colorectal cancer. Dis Colon Rectum. 43:(5):2000;656-661.
56. Tabuse K. A new operative procedure of hepatic surgery using a microwave tissue coagulator. Nippon Geka Hokan. 48:(2):1979;160-172.
57. Shibata T., Niinobu T., Ogata N., Takami M. Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer. 89:(2):2000;276-284.
58. Malik U., Mohiuddin M. External-beam radiotherapy in the management of liver metastases. Semin Oncol. 29:2002;196-201.
59. National Cancer Institute Cancer Therapy Evaluation Program. Response Evaluation Criteria in Solid Tumors. Available at: http://ctep.cancer.gov/ guidelines/recist.html. Accessed January 2, 2004.
60. Stubbs R.S., Cannan R.J., Mitchell A.W. Selective internal radiation therapy with 90yttrium microspheres for extensive colorectal liver metastases. J Gastrointest Surg. 5:(3):2001;294-302.
61. Koniaris L.G., Chan D.Y., Magee C., Solomon S.B., Anderson J.H., Smith D.O., et al. Focal hepatic ablation using interstitial photon radiation energy. J Am Coll Surg. 191:(2):2000;164-174.
62. Kosari K., Gomes M., Hunter D., Hess D.J., Greeno E., Sielaff T.D. Local, intrahepatic, and systemic recurrence patterns after radiofrequency ablation of hepatic malignancies. J Gastrointest Surg. 6:(2):2002;255-263.